NET Connect Meeting Series
November 17, 2021
Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.
Please join us for the second instalment of the nurse meeting series NET Connect. At this webinar you will hear from local experts and contribute
A note from our CEO on COVID-19: To our wonderful NET community we stand with you and alongside you as we get through this unprecedented
We are delighted to invite you to the ENETS-INCA NET Cancer Day Educational Webinar on Wednesday, 10 November 2021. This webinar addresses explicitly the patients’
KNOXVILLE, TN, Sept. 21, 2021 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced that data from an ongoing clinical trial of investigational cancer immunotherapy PV-10
All donations are tax deductible.
Registered Charity CFN 202607
© 2020 NeuroEndocrine Cancer Australia